The M5 and M10 network modules and their hub proteins similarly differentiate C9orf72 ALS from asymptomatic mutation carriers (see Fig. 3), suggesting these may reflect more generalized biomarkers of active disease. This evidence concerns the gene C9orf72 and amyotrophic lateral sclerosis.